All sponsors

Kyowa Kirin Co., Ltd. $4151.T

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-31
RECRUITING3
READOUTS ≤12 MONTHS2
Open Kyowa Kirin Co., Ltd. on the live radar map → 📅 $4151.T readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
KHK4951
NCT06116916
P2Active, not recruitingDiabetic Macular Edema (DME)1852026-10-31 (+12 mo)
ziftomenib
NCT07623616
P2RecruitingAcute Myeloid Leukemia (AML)62027-03
KK2430
NCT07629726
P1/2RecruitingHematologic Neoplasms722027-04
ME-401
NCT04533581
P2Active, not recruitingIndolent B-cell Non-Hodgkin's Lymphoma612028-05-31 (+45 mo)
KK8398
NCT06926491
P3Active, not recruitingAchondroplasia132029-05-31
KK8123
NCT06525636
P1/2RecruitingX-linked Hypophosphatemia392030-06-14 (+28 mo)